2023年2月7日—安森美(onsemi，美国纳斯达克股票代号：ON)公布其2022年第4季度及全年业绩，亮点如下：
- 第4季度收入21.036亿美元，同比增长14%
- 第4季度公认会计原则(以下简称“GAAP") 毛利率分别48.5%，同比增长343基点，非公认会计原则(以下简称“non-GAAP")毛利率48.4%，同比增长321基点
- 第4季度破纪录汽车行业收入9.89亿美元，同比增长54%
- 第4季度GAAP和non-GAAP每股摊薄盈利分别为1.35美元和1.32美元
- 破纪录2022财年全年收入83亿美元，同比增长24%
- 2022年GAAP和non-GAAP毛利率分别为49.0%和49.2%
- 2022财年自由现金流同比增长22%，占收入的20%
安森美总裁兼首席执行官(CEO) Hassane El-Khoury说：“ 公司上下的高度执行力及战略转型，确保我们在2022年取得了出色的业绩。2022年全年收入同比增长了24%，non-GAAP毛利率增长了880基点，non-GAAP营运利润增长速度是收入的四倍，这是因为我们专注于电动汽车、先进驾驶辅助系统(ADAS)、替代能源和工业自动化等长期大趋势。我们致力于关键战略举措，如提升碳化硅的产量以支持长期供应协议。尽管目前宏观经济存在不确定性，但我们业务的长期前景仍然强劲，我们的设计导入总量同比增长了38%。"
安森美还宣布，其董事会已批准了一项新的股票回购计划，授权在2025年12月31日前回购达30亿美元的公司普通股。
安森美执行副总裁兼首席财务官Thad Trent说：“我们致力于推动平衡的资本分配战略，为股东带来长期价值。董事会和领导团队有信心以我们的投资战略促进长期盈利增长，很高兴地宣布新的30亿美元股票回购授权。自我们开始转型之旅以来，自由现金流增加了三倍，因此我们的回购授权是之前授权 (2022年12月31日到期) 的两倍，提升了灵活度。"
根据新的股票回购计划，安森美可以随时通过公开市场购买、私下协商交易或其他方式回购股票，包括采用符合1934年证券交易法10b5-1规则的交易计划，根据适用的证券法和其他限制条件修订。股票回购的时间和总额将取决于业务、经济和市场条件、公司和监管要求、当时的股票价格和其他考量。该授权将于2025年12月31日到期，可随时暂停或终止，且不要求公司收购任何数量的普通股。
下表概列2022年第4季度与可比较时期的部分财务业绩:
2023年第1季度展望
下表概列安森美预计2023年第1季度的GAAP及non-GAAP展望：
FINANCIALS
* Diluted shares outstanding can vary as a result of, among other things, the actual exercise of options or vesting of restricted stock units, the incremental dilutive shares from the Company's convertible senior subordinated notes, and the repurchase or the issuance of stock or convertible notes or the sale of treasury shares. In periods when the quarterly average stock price per share exceeds $20.72 for the 1.625% Notes and $52.97 for the 0% Notes, the non-GAAP diluted share count and non-GAAP net income per share include the anti-dilutive impact of the Company’s hedge transactions issued concurrently with the 1.625% Notes and the 0% Notes, respectively. At an average stock price per share between $20.72 and $30.70 for the 1.625% Notes and $52.97 and $74.34 for the 0% Notes, the hedging activity offsets the potentially dilutive effect of the 1.625% Notes and 0% Notes, respectively. In periods when the quarterly average stock price exceeds $30.70 for the 1.625% Notes, and $74.34 for the 0% Notes, the dilutive impact of the warrants issued concurrently with such notes are included in the diluted shares outstanding GAAP and non-GAAP diluted share counts and are based on either the Company's previous quarter's average stock price or the stock price as of the last day of the previous quarter, whichever is higher.
** Special items may include: amortization of acquisition-related intangibles; expensing of appraised inventory fair market value step-up; purchased in-process research and development expenses; restructuring, asset impairments and other, net; goodwill impairment charges; gains and losses on debt prepayment; non-cash interest expense; actuarial (gains) losses on pension plans and other pension benefits; and certain other special items, as necessary. These special items are out of our control and could change significantly from period to period. As a result, we are not able to reasonably estimate and separately present the individual impact or probable significance of these special items, and we are similarly unable to provide a reconciliation of the non-GAAP measures. The reconciliation that is unavailable would include a forward-looking income statement, balance sheet and statement of cash flows in accordance with GAAP. For this reason, we use a projected range of the aggregate amount of special items in order to calculate our projected non-GAAP operating expense outlook.
*** We believe these non-GAAP measures provide important supplemental information to investors. We use these measures, together with GAAP measures, for internal managerial purposes and as a means to evaluate period-to-period comparisons. However, we do not, and you should not, rely on non-GAAP financial measures alone as measures of our performance. We believe that non-GAAP financial measures reflect an additional way of viewing aspects of our operations that, when taken together with GAAP results and the reconciliations to corresponding GAAP financial measures that we also provide in our releases, provide a more complete understanding of factors and trends affecting our business. Because non-GAAP financial measures are not standardized, it may not be possible to compare these financial measures with other companies' non-GAAP financial measures, even if they have similar names.
电话会议
安森美已于美国东部时间（EST）2023年2月6日上午9时为金融界举行电话会议，讨论此次的发布及安森美2022年第4季度及全年业绩。英语电话会议已在公司网站http://www.onsemi.cn的“投资者关系"网页作实时广播。实时网上广播大约1小时后在该网站回放，为时30天。 投资者及有兴趣者如想参加业绩报告英语电话会议可在这里预先注册。
This document includes “forward-looking statements," as that term is defined in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements, other than statements of historical facts, included or incorporated in this document could be deemed forward-looking statements, particularly statements about the future financial performance of onsemi, including financial guidance for the first fiscal quarter of 2023, and statements regarding our new share repurchase program. Forward-looking statements are often characterized by the use of words such as “believes," “estimates," “expects," “projects," “may," “will," “intends," “plans," “anticipates," “should" or similar expressions or by discussions of strategy, plans or intentions. All forward-looking statements in this document are made based on our current expectations, forecasts, estimates and assumptions and involve risks, uncertainties, and other factors that could cause results or events to differ materially from those expressed in the forward-looking statements. Certain factors that could affect our future results or events are described under Part I, Item 1A “Risk Factors" in our 2021 Annual Report on Form 10-K filed with the Securities and Exchange Commission (“SEC") on February 14, 2022 (our “2021 Form 10-K") and Part II, Item IA “Risk Factors" in each of our Quarterly Reports on Form 10-Q filed with the SEC for the quarters ended April 1, 2022, July 1, 2022, and September 30, 2022, and from time-to-time in our other SEC reports (including in our 2022 Form 10-K). Readers are cautioned not to place undue reliance on forward-looking statements. We assume no obligation to update such information, except as may be required by law. Investing in our securities involves a high degree of risk and uncertainty, and you should carefully consider the trends, risks, and uncertainties described in this document, our 2021 Form 10-K and other reports filed with or furnished to the SEC before making any investment decision with respect to our securities. If any of these trends, risks, or uncertainties actually occurs or continues, our business, financial condition or operating results could be materially adversely affected, the trading prices of our securities could decline, and you could lose all or part of your investment. All forward-looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by this cautionary statement.
